Jump To

Coagadex

Generic name: coagulation factor X
Drug class: Miscellaneous coagulation modifiers

Medically reviewed by  A Ras MD.

What is Coagadex?

Coagadex is a prescription medicine that is used to treat or prevent bleeding.

Description

COAGADEX is a plasma-derived, sterile, purified concentrate of human coagulation Factor X that contains sucrose as a stabilizer. It is formulated as a lyophilized powder for solution for intravenous administration. When reconstituted with Sterile Water for Injection it forms a colorless, clear or slightly pearl-like solution. COAGADEX contains nominally (approximately) 100 IU/mL of coagulation Factor X and the following inactive ingredients: chloride, phosphate, citrate, sucrose and sodium. Each vial of COAGADEX is labeled with the actual Factor X activity/content expressed in IU per vial. Factor X activity in IU is determined using an in vitro chromogenic assay and a Factor X concentrate reference standard calibrated against the WHO 3rd International Standard for Blood Coagulation Factors II and X Concentrate.

COAGADEX contains no added biological components such as heparin, albumin or anti-thrombin. The content of Factor II and Factor IX are ≤ 1 IU/mL of the reconstituted product. Factor Xa and Factor IIa were not detectable by Non-activated Partial Thromboplastin Time (NaPTT) or Fibrinogen Clotting Time (FCT) tests for potential thrombogenicity, and comprised < 10 parts per million by weight when tested by more sensitive analytical methods. The specific activity of COAGADEX is typically 80-137 IU per mg protein. The product contains no preservatives.

COAGADEX is manufactured from plasma, obtained from healthy US donors, who have passed viral screening tests. All donors are subjected to medical examinations, laboratory tests, and a review of their medical history before being allowed to donate blood or plasma.

All plasma donations are screened for antibody to human immunodeficiency virus (HIV)-1/2, hepatitis C virus (HCV), and hepatitis B surface antigen (HBsAg). Additional testing of donations is carried out in plasma mini-pools (512 donations per pool) with nucleic acid amplification testing (NAT) for HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis A virus (HAV) and human parvovirus B19. Furthermore, each manufacturing pool is tested to be negative for HBsAg and anti-HIV-1/2 antibodies. Also, manufacturing pools are non-reactive by nucleic acid test for HAV, HBV, HCV, and HIV-1. The limit for human parvovirus B19 in the manufacturing pools is set not to exceed 104 IU/mL.

Three processing steps specifically designed to remove or inactivate viruses are:

1) Solvent/detergent treatment targeted to inactivate enveloped viruses

2) A 15-nm filtration step designed to remove small viruses including non-enveloped viruses

3) Terminal dry-heat treatment at 80°C for 72 hours in the final container to inactivate enveloped and non-enveloped viruses

The capacity of the manufacturing process to remove and/or inactivate enveloped and non-enveloped viruses has been validated by laboratory spiking studies on a scaled-down process model. Overall virus reduction was calculated only from steps that were mechanistically independent from each other. Table 2 presents the contribution of each process step to virus reduction and the overall process reduction.

 

Table 2 Viral Reduction by Process Step
Process Log10 Reduction of Virus (LRV) over manufacturing step
Virus Type
(Envelope/Genome)
Size
(nm)
Solvent/detergent 15-nm filtration Terminal dry-heat treatment Total LRV
HIV: Human immunodeficiency virus
SIN: Sindbis virus, model for HCV
WNV: West Nile Virus
BVDV: Bovine viral diarrhea virus, model for HCV
IBR: Infectious bovine rhinotracheitis, bovine herpes virus model for enveloped DNA viruses including HBV
HAV: Hepatitis A virus
HSV: Herpes simplex virus
CPV: Canine parvovirus, model for human parvovirus B19
NA: Not applicable, solvent/detergent treatment step is limited to the inactivation of enveloped viruses
NT: Not tested
*
Studies using human parvovirus B19, which are considered experimental in nature, have demonstrated a virus reduction factor of > 5.9 log10 by 15-nm filtration using a PCR method
HIV Env/RNA 80-100 > 4.6 > 6.8 5.5 > 16.9
SIN Env/RNA 60-70 6.0 NT NT 6.0
BVDV Env/RNA 50-70 > 5.1 > 4.5 > 5.2 > 14.8
HSV Env/DNA 120-200 > 5.4 5.8 3.5 > 14.7
IBR Env/DNA 120-200 > 5.3 NT NT > 5.3
WNV Env/RNA 40-60 4.9 NT NT 4.9
HAV Non-Env/RNA 25-30 NA > 5.0 > 6.1 > 11.1
CPV Non-Env/RNA 18-24 NA 4.3* 4.2 8.5

Mechanism of Action

COAGADEX temporarily replaces the missing Factor X needed for effective hemostasis. Factor X is an inactive zymogen, which can be activated by Factor IXa (via the intrinsic pathway) or by Factor VIIa (via the extrinsic pathway). Factor X is converted from its inactive form to the active form (Factor Xa) by the cleavage of a 52-residue peptide from the heavy chain. Factor Xa associates with Factor Va on a phospholipid surface to form the prothrombinase complex, which activates prothrombin to thrombin in the presence of calcium ions. Thrombin then acts upon soluble fibrinogen and Factor XIII to generate a cross-linked fibrin clot.

Before taking Coagadex, tell your doctor:

  • If you are allergic to Coagadex; any part of this medicine; or any other drugs, foods, or substances. Tell your doctor about the allergy and what signs you had.

This medicine may interact with other drugs or health problems.

Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take Coagadex with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor.

What are some things I need to know or do while I take Coagadex?

  • Tell all of your health care providers that you take Coagadex. This includes your doctors, nurses, pharmacists, and dentists.
  • Have blood work checked as you have been told by the doctor. Talk with the doctor.
  • Call the doctor right away if the normal dose does not work as well.
  • This medicine is made from human plasma (part of the blood) and may have viruses that may cause disease. This medicine is screened, tested, and treated to lower the chance that it carries an infection. Talk with the doctor.
  • Talk with the doctor before you travel. You will need to bring enough of Coagadex for use during travel.
  • Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using Coagadex while you are pregnant.
  • Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.

How is Coagadex best taken?

Use Coagadex as ordered by your doctor. Read all information given to you. Follow all instructions closely.

  • It is given as a shot into a vein.
  • If you will be giving yourself the shot, your doctor or nurse will teach you how to give the shot.
  • Wash your hands before and after use.
  • This medicine needs to be mixed before use. Follow how to mix as you were told by the doctor.
  • If stored in a refrigerator, let Coagadex come to room temperature before mixing. Do not heat Coagadex.
  • Do not shake.
  • Use within 1 hour after mixing.
  • Do not use if the solution is cloudy, leaking, or has particles.
  • Do not use if solution changes color.
  • Throw away any part of opened vial not used after use.
  • Throw away needles in a needle/sharp disposal box. Do not reuse needles or other items. When the box is full, follow all local rules for getting rid of it. Talk with a doctor or pharmacist if you have any questions.

What do I do if I miss a dose?

  • Call your doctor to find out what to do.

What are the side effects of Coagadex that I need to call my doctor about immediately?

WARNING/CAUTION: Even though it may be rare, some people may have very bad and sometimes deadly side effects when taking a drug. Tell your doctor or get medical help right away if you have any of the following signs or symptoms that may be related to a very bad side effect:

  • Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing, swallowing, or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.
  • Burning, stinging, or redness where Coagadex goes into the body.
  • Fever or chills.
  • Dizziness or passing out.
  • Flushing.
  • Headache.
  • Feeling very tired or weak.
  • Muscle pain.
  • Upset stomach or throwing up.
  • Restlessness.
  • A fast heartbeat.
  • Tingling.
  • Wheezing or coughing.

What are some other side effects of Coagadex?

All drugs may cause side effects. However, many people have no side effects or only have minor side effects. Call your doctor or get medical help if any of these side effects or any other side effects bother you or do not go away:

  • Pain where the shot was given.
  • Feeling tired or weak.
  • Back pain.

These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.

You may report side effects to the FDA at 1-800-332-1088. You may also report side effects at https://www.fda.gov/medwatch.

If overdose is suspected:

If you think there has been an overdose, call your poison control center or get medical care right away. Be ready to tell or show what was taken, how much, and when it happened.

How do I store and/or throw out Coagadex?

  • Store at room temperature or in a refrigerator. Do not freeze.
  • Store in the original container to protect from light.
  • Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.
  • Throw away unused or expired drugs. Do not flush down a toilet or pour down a drain unless you are told to do so. Check with your pharmacist if you have questions about the best way to throw out drugs. There may be drug take-back programs in your area.

Label

PRINCIPAL DISPLAY PANEL – 250 IU VIAL LABEL

  • Coagulation Factor X
    (Human)
    Coagadex®
  • 250 IU Range
  • FOR INTRAVENOUS USE ONLY.
  • Read enclosed package insert before use.
  • Rx only.
  • Store between 36°F – 86°F (2°C – 30°C).
  • DO NOT FREEZE.
  • NDC: 64208-7754-1
  • FXRNUS2L
PRINCIPAL DISPLAY PANEL - 250 IU Vial Label

PRINCIPAL DISPLAY PANEL – 2.5 ML VIAL LABEL

  • Sterile Water
    for Injection
  • 2.5 mL
  • Store between 36°F – 86°F (2°C – 30°C).
    Do not freeze.
    Do not use unless clear.
    NDC: 64208-7755-1
  • Bio Products Laboratory Ltd., Elstree,
    WD6 3BX, United Kingdom
    WWBNUS2L
PRINCIPAL DISPLAY PANEL - 2.5 mL Vial Label

SRC: NLM .

Read Next Article

PHP Code Snippets Powered By : XYZScripts.com